CompaniesCrealta Pharmaceuticals

Crealta Pharmaceuticals

defunct

About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (62)

View all

Total Trials

As Lead Sponsor

As Collaborator

Total Enrollment

25,201

By Phase

PHASE4: 25PHASE2: 6PHASE3: 8PHASE1: 7NA: 1

By Status

COMPLETED: 45UNKNOWN: 10RECRUITING: 3TERMINATED: 3NOT_YET_RECRUITING: 1

Clinical Trials Pipeline62 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

2027

2028

2029

Today

NCT00216749

Efficacy and Safety of Cilostazol for the Indication of CSPS

Phase: N/A

Role: Lead Sponsor

Start: Dec 31, 2003

Completion: Oct 31, 2007

NCT00216723

Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar Disorder

Phase: N/A

Role: Lead Sponsor

Start: Apr 30, 2004

Completion: Dec 31, 2009

NCT00216723

NCT00304655

Acute Psychosis Treatment in the Long Term, Unitary Group Study (APLUS)

Phase: Phase 4

Role: Lead Sponsor

Start: Jul 31, 2004

Completion: Oct 31, 2007

NCT00304616

SWitching to Abilify Trial (SWAT)

Phase: Phase 4

Role: Lead Sponsor

Start: Oct 31, 2004

Completion: Oct 31, 2007

NCT00272467

Healing Effects of Rebamipide and Omeprazole in Helicobacter Pylori-positive Gastric Ulcer After Eradication Therapy

Phase: Phase 4

Role: Collaborator

Start: Jul 31, 2005

Completion: Apr 30, 2008

NCT00328367

Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory Schizophrenia

Phase: Phase 4

Role: Collaborator

Start: Dec 31, 2005

Completion: Feb 29, 2008

NCT00272454

Cilostazol in Acute Ischemic Stroke Treatment (CAIST)

Phase: Phase 4

Role: Lead Sponsor

Start: Jan 31, 2006

Completion: Sep 30, 2008

NCT00741286

Effect of Cilostazol in the Acute Lacunar Infarction Based on Pulsatility Index of Transcranial Doppler

Phase: Phase 4

Role: Collaborator

Start: Nov 30, 2006

Completion: Oct 31, 2008

NCT00446641

Overcome Biochemical Aspirin Resistance Through Cilostazol Combination

Phase: Phase 4

Role: Collaborator

Start: Mar 31, 2007

Completion: Jul 31, 2008

NCT00545142

Abilify in Bipolar Disorder for 6 Weeks Treatment Effectiveness

Phase: Phase 4

Role: Lead Sponsor

Start: Oct 31, 2007

Completion: Jun 30, 2010

NCT00549952

Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer Patients

Phase: N/A

Role: Lead Sponsor

Start: Oct 31, 2007

Completion: Mar 31, 2008

NCT00549978

Safety and Pharmacokinetics of Probucol and Cilostazol

Phase: Phase 4

Role: Lead Sponsor

Start: Oct 31, 2007

Completion: Aug 31, 2008

NCT00545675

Abilify in Bipolar Disorder for 24 Weeks Treatment Effectiveness

Phase: Phase 4

Role: Lead Sponsor

Start: Dec 31, 2007

Completion: Jul 31, 2010

NCT00576706

PReventive Efficacy and Safety of rEbamipide on Nsaid Induced Mucosal Toxicity

Phase: Phase 3

Role: Lead Sponsor

Start: Dec 31, 2007

Completion: Mar 31, 2010

NCT00569504

Prevalence of the Metabolic Syndrome in SPR Taking Antipsychotics

Phase: N/A

Role: Collaborator

Start: Dec 31, 2007

Completion: Sep 30, 2009

NCT00569764

Effect on Metabolic Parameters of Abilify in SPR

Phase: N/A

Role: Collaborator

Start: Dec 31, 2007

Completion: Oct 31, 2009

NCT00657176

An Open-Label Phase-1 Study of OPB-31121 in Patients With Advanced Solid Tumors

Phase: Phase 1

Role: Lead Sponsor

Start: Mar 31, 2008

Completion: Jun 30, 2009

NCT00706589

Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's Disorder

Phase: Phase 3

Role: Lead Sponsor

Start: Oct 31, 2008

Completion: Apr 30, 2010

NCT00845988

Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar Disorders

Phase: Phase 4

Role: Collaborator

Start: Dec 31, 2008

Completion: Mar 31, 2012

NCT01000467

Pharmacokinetics Study for Probucol

Phase: Phase 4

Role: Lead Sponsor

Start: Feb 28, 2009

Completion: Sep 30, 2009

NCT01043250

Effects of Atypical Antipsychotics on Appetite and Eating Behavior of Schizophrenia Patients

Phase: N/A

Role: Collaborator

Start: May 31, 2009

Completion: Dec 31, 2010

NCT01013532

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Phase: Phase 4

Role: Collaborator

Start: Jun 30, 2009

Completion: Dec 31, 2016

NCT01013532

NCT02483169

PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT Study

Phase: Phase 4

Role: Collaborator

Start: Jun 30, 2009

Completion: Dec 31, 2016

NCT02483169

NCT00993317

A Study of CDP870 as Add-on Meditation to Methotrexate (MTX) in Patients With Rheumatoid Arthritis

Phase: Phase 3

Role: Lead Sponsor

Start: Oct 31, 2009

Completion: Aug 31, 2011

NCT01026584

Efficacy and Safety of Aripiprazole in First Episode Psychosis

Phase: Phase 4

Role: Collaborator

Start: Oct 31, 2009

Completion: Feb 29, 2012

NCT01031667

Synergistic Effect of Combination Therapy With Cilostazol and Probucol on Plaque Stabilization and Lesion Regression: Serial Intravascular Ultrasound and Virtual Histology Study(SECURE Study)

Phase: Phase 4

Role: Collaborator

Start: Nov 30, 2009

Completion: Jun 30, 2011

NCT01014416

Pharmacokinetics/Pharmacodynamics (PK/PD) Characteristics of Tolvaptan Tablet in Korean Healthy Male

Phase: Phase 1

Role: Lead Sponsor

Start: Jan 31, 2010

Completion: Mar 31, 2010

NCT01197066

Open-label, Extension Study of CDP870 in Patients With Rheumatoid Arthritis

Phase: Phase 3

Role: Lead Sponsor

Start: Mar 31, 2010

Completion: Nov 30, 2016

NCT01197066

NCT01142284

Evaluation of Concomitant Administration of Cilostazol and Probucol on Biomarkers, Endothelial Function and Safety

Phase: Phase 2

Role: Lead Sponsor

Start: May 19, 2010

Completion: Dec 18, 2012

NCT01284959

Different Safety Profile of Risperidone and Paliperidone Extended-release

Phase: Phase 4

Role: Collaborator

Start: Jun 30, 2010

Completion: Dec 31, 2010

NCT01291641

Effect of Probucol and/or Cilostazol on Mean IMT in Patients With Coronary Heart dIsease

Phase: Phase 4

Role: Collaborator

Start: Mar 31, 2011

Completion: Mar 31, 2017

NCT01291641

NCT01378650

A Study on the Effect of Cilostazol in Patients With Chronic Tinnitus

Phase: N/A

Role: Collaborator

Start: Jul 31, 2011

Completion: Jun 30, 2013

NCT01444885

Evaluate the Efficacy and Safety of Pletaal (Cilostazol) in Subjects With Vasospastic Angina

Phase: Phase 2

Role: Lead Sponsor

Start: Oct 31, 2011

Completion: Jul 31, 2012

NCT01552590

Effect of Samsca on Control of Hyponatremia and Extracellular Fluid in Cirrhotic Patients With Ascites

Phase: Phase 4

Role: Lead Sponsor

Start: Apr 30, 2012

Completion: Apr 30, 2012

NCT01795105

ABF Tourette's Disorder Post Marketing Surveillance Study

Phase: N/A

Role: Lead Sponsor

Start: Jun 30, 2012

Completion: May 29, 2015

NCT01711333

A Study to Evaluate the Efficacy and Safety of Pletaal SR Capsule (Cilostazol) in Subjects With Peripheral Arterial Disease Symptom Due to Chronic Occlusive Arterial Disease

Phase: Phase 4

Role: Lead Sponsor

Start: Oct 26, 2012

Completion: Aug 18, 2014

NCT01726816

Efficacy and Safety Study of Probucol in Patients With Diabetic Nephropathy

Phase: Phase 2

Role: Lead Sponsor

Start: Oct 31, 2012

Completion: Sep 30, 2014

NCT02352285

Outcome and Treatment Quality Study of Tolvaptan to Treat Hyponatremia in Patients With Heart Failure

Phase: Phase 4

Role: Lead Sponsor

Start: Dec 31, 2012

Completion: Jan 31, 2017

NCT01782833

Pletaal SR Post Marketing Observational Study

Phase: N/A

Role: Lead Sponsor

Start: Jan 31, 2013

Completion: Dec 31, 2014

NCT01923935

Busulfan and Melphalan Conditioning in Multiple Myeloma

Phase: Phase 2

Role: Collaborator

Start: Jan 31, 2013

Completion: Dec 31, 2015

NCT01942083

A Phase I, Open Label, Non Randomized, Multicenter, Dose Escalation Clinical Study to Investigate Safety and Tolerability of OPB(Otsuka Pharmaceutical Biwa)-111077 in Subjects With Advanced HCC(Hepatocellular Carcinoma)

Phase: Phase 1

Role: Lead Sponsor

Start: May 29, 2013

Completion: Jul 11, 2016

NCT02722863

Samsca Post Marketing Surveillance Study

Phase: N/A

Role: Lead Sponsor

Start: Jul 9, 2013

Completion: Jun 15, 2017

NCT01925521

OPS-2071 Single and Multiple Dose Study to Investigate PK and PD Profile in Healthy Korean Male Subjects.

Phase: Phase 1

Role: Lead Sponsor

Start: Aug 31, 2013

Completion: Apr 30, 2014

NCT01961882

A Phase 2 Trial to Evaluate the Efficacy and Safety of OCV-501 in Elderly Patients With Acute Myeloid Leukemia

Phase: Phase 2

Role: Collaborator

Start: Oct 31, 2013

Completion: Nov 16, 2017

NCT02087007

A Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Cilostazol in Subjects With Vasospastic Angina

Phase: Phase 3

Role: Lead Sponsor

Start: Nov 30, 2013

Completion: Jul 31, 2015

NCT02094469

Safety and Efficacy Study of Cilostazol to Treat Vasospastic Angina

Phase: Phase 3

Role: Lead Sponsor

Start: Dec 31, 2013

Completion: Jan 31, 2016

NCT02250170

Safety and Biomarker of OPB-111077 in Subjects With Advanced Solid Tumor

Phase: Phase 1

Role: Lead Sponsor

Start: Oct 23, 2014

Completion: Mar 8, 2019

NCT02250170

NCT04407312

Cilostazol and Endothelial Progenitor Cell

Phase: Phase 4

Role: Collaborator

Start: Jan 1, 2016

Completion: Jul 31, 2020

NCT04407312

NCT03406286

Samsca PMS in ADPKD Patients

Phase: N/A

Role: Lead Sponsor

Start: Jul 19, 2016

Completion: Dec 31, 2024

NCT03406286

NCT03386851

Abilify Maintena PMS in Schizophrenia Patients or Bipolar 1 Disorder

Phase: N/A

Role: Lead Sponsor

Start: Dec 13, 2016

Completion: May 25, 2021

NCT03386851

NCT03470233

Post Marketing Registry to Assess Usage, Safety and Effectiveness of Deltyba Tablets in Korean Patients With MDR-TB

Phase: N/A

Role: Lead Sponsor

Start: May 25, 2017

Completion: Jun 21, 2021

NCT03376763

MAintain the Efficacy and Safety in Treatment of Schizophrenia After Switching to Long-acTing Injectable aRipiprazole From Oral Atypical Antipsychotics

Phase: Phase 4

Role: Lead Sponsor

Start: Nov 21, 2017

Completion: Nov 19, 2021

NCT03423680

A Study of Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Bipolar Depression

Phase: Phase 3

Role: Lead Sponsor

Start: Feb 22, 2018

Completion: Dec 31, 2025

NCT03423680

NCT03709017

Iclusig PMS in CML or Ph+ALL Patients

Phase: N/A

Role: Lead Sponsor

Start: Aug 7, 2018

Completion: Jun 30, 2023

NCT03709017

NCT04150172

To Evaluate Pharmacokinetics and Safety of Two Different Formulation of Rebamipide in Healthy Volunteers

Phase: Phase 1

Role: Lead Sponsor

Start: Apr 22, 2019

Completion: May 10, 2019

NCT03949894

Evaluating the Safety and effectivenesS in Adult KorEaN Patients Treated With Tolvaptan for Management of Autosomal domInAnt poLycystic Kidney Disease

Phase: Phase 4

Role: Lead Sponsor

Start: Jul 1, 2019

Completion: May 25, 2022

NCT04150146

To Evaluate Food Effect on the Pharmacokinetics of Rebamipide in Healthy Volunteers

Phase: Phase 1

Role: Lead Sponsor

Start: Jul 5, 2019

Completion: Jul 24, 2019

NCT04189705

A Study to Evaluate the Efficacy and Safety of MCT-SR in Patients With Gastritis